Sign in
GWLL Stock Price, Chart, Stats & News
Goldenwell Biotech, Inc.
Save
Goldenwell Biotech, Inc. (GWLL) does not currently pay a dividend.
69.30M
Market cap
–
Current P/E
–
Forward P/E
GWLL chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Similar securities
Based on sector and market capitalization
Report issue